Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.63281 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.47104 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.54641 | 59 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.47896 | 59 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.47576 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.68434 | 60 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.54818 | 57 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.51283 | 58 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.77649 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.37835 | 56 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.45351 | 57 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.73407 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.52868 | 58 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.46223 | 57 |